Arbutus Biopharma Corp (ABUS)

Finanzdaten der Arbutus Biopharma Corp-Aktie (ABUS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	99.43%1.01	179.13	1.05	0.53	10.74
	31.71%6.98	10.22	6.34	9.19	9.25
Research and Development	29.66%2.90	4.12	5.01	5.78	5.50
Operating Income/Loss	103.53%-5.96	168.91	-5.29	-8.66	1.49
Nonoperating Income/Loss	4.32%0.82	0.79	1.53	0.92	1.04
Income Tax Expense/Benefit	-	-	-	-	-
	103.03%-5.14	169.70	-3.76	-7.74	2.52
Attributable To Parent	103.03%-5.14	169.70	-3.76	-7.74	2.52
Basic Average Shares	1.91%197.47	193.77	-	191.78	191.55
Diluted Average Shares	1.16%197.47	195.21	-	191.78	192.40
Basic Earnings Per Share	103.41%-0.03	0.88	-	-0.04	0.01
Diluted Earnings Per Share	103.45%-0.03	0.87	-	-0.04	0.01